Scientists find link between master gene and neurodegenerative disorders

Scientists find link between master gene and neurodegenerative disorders

Garbage comes in all shapes and sizes. Cells, the body's functional units of life, also produce 'garbage' - debris and dysfunctional elements the body must get rid of. Failure to dispose of this garbage could trigger various neurodegenerative disorders in adult life, including Parkinson's disease, and rare genetic diseases in children. The latter diseases are called lysosomal storage disorders and include Fabry and Batten diseases.

An international team of scientists, funded in part by a European Research Council (ERC) grant under the EU's Seventh Framework Programme (FP7), has discovered a master gene that controls both the that break up the debris as well as the cellular compartments that encapsulate the material and fuse with lysosomes to completely dispose of the debris. The findings, presented in the journal Science, could lead to the development of new ways to fight these diseases, both for the young and old.

'The master gene (transcription factor EB or TEFB) controls the function of lysosomes (organelles in the cell that break down waste and cellular debris) and controls the function of autophagosomes [cellular compartments],' explains Dr Andrea Ballabio of the Telethon Institute of Genetics and Medicine (TIGEM) in Naples, Italy, a professor of molecular and at Baylor College of Medicine (BCM) and the Texas Children's Neurological Research Institute (NRI) in the United States and senior author of the study. 'Defects in this process are also implicated in neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.'

Professor Ballabio equates the autophagosomes to 'garbage trucks' that transfer the debris they pick up to the lysosomes that 'incinerate' it. Finding the single with the capacity to control this activity is 'one of the few examples of coordinated regulation of two cellular compartments,' he points out.

The researchers had already determined that TEFB regulates the creation and development of lysosomes, effectively increasing their number. The question for them was to find out how the gene could be used to boost the cell's capacity to dispose of waste products. The key link was getting more autophagosomes.

'We thought there would be no point in increasing the incinerators unless we could also increase the garbage trucks,' Professor Ballabio says. TEFB, say the researchers, controls both activities.

Commenting on the research, lead author Dr Carmine Settembre, also from TIGEM, BCM and NRI, says: 'This understanding paves the way to finding drugs to activate the process.' Professor Ballabio goes on to say how brilliant a tool this gene is. 'By modulating the activity of a single gene, we can induce the activity of a variety of other genes that are involved in the process of degradation.'

Researchers from the Cambridge Institute for Medical Research of the University of Cambridge in the United Kingdom contributed to this study.

Commenting on the trans-Atlantic collaboration, NRI Director Dr Huda Zoghbi says: 'Collaborations are the best way to accelerate discovery and advance the search for ways to impact neurological disorders. This partnership between NRI, BCM and Telethon Institute of Genetics and Medicine is a fine example of the power of collaborations.'

add to favorites email to friend print save as pdf

Related Stories

Gene therapy slows progression of Batten Disease

Jun 02, 2008

Gene therapy that helps defective brain cells get rid of "garbage" appears both safe and effective at slowing down Batten disease, according to promising findings from NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

Recommended for you

The secret of DNA methylation

7 hours ago

Methylation refers to a chemical modification of DNA and this modification can occur in millions of positions in the DNA sequence. Until now, scientists believed that this epigenetic phenomenon actively reduced the expression ...

Aspirin may fight cancer by slowing DNA damage

9 hours ago

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...

Study identifies protein essential for normal heart function

Jun 17, 2013

A study by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences and the Department of Pharmacology at the University of California, San Diego, shows that a protein called MCL-1, which promotes cell survival, ...

Scouring the genome of adenoid cystic carcinoma

Jun 17, 2013

Adenoid cystic carcinoma (ACC) is a slow-growing and often fatal malignancy that can occur at multiple organ site, but is most frequently found in the salivary glands. The primary treatment is surgical removal; however, the ...

Gene variants may play role in obesity

Jun 17, 2013

(HealthDay)—Two new studies offer some solace to those who can't control their weight despite diet and exercise by providing more evidence that genetics may play a role in obesity.

Decoding Rett syndrome: New pieces to the puzzle

Jun 17, 2013

(Medical Xpress)—Rett Syndrome is a neurological disorder that affects about 1 in 10,000 girls. Back in 1992, University of Edinburgh researcher Adrian Bird discovered that the protein, MeCP2, plays a major ...

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...